DNDonny Nauphar

Donny Nauphar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Donny Nauphar has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Relationship between the TCF7L2 rs7903146 Gene Polymorphism and Anthropometric Parameters and Muscle Mass among Patients with Type 2 Diabetes Mellitus at Puskesmas Waruroyom, Cirebon

    by Muhammad Ajmalunnas, Yuni Susanti Pratiwi, Tiar Masykuroh Pratamawati, Donny Nauphar, Edhyana Sahiratmadja, Leonardo Lubis

    Background: Polymorphism of the TCF7L2 gene (rs7903146) is involved in glucose homeostasis and has been strongly associated with type 2 diabetes mellitus (T2DM). However, its relationship with anthropometric characteristics, particularly by glycemic control status, remains unclear. Subjects and Method: This cross-sectional study included 75 patients with type 2 diabetes mellitus (T2DM) in the working area of Puskesmas Waruroyom, Cirebon. The target population comprised all registered T2DM patients, and total sampling was applied through screening. Subjects were classified into controlled (n = 37; 49.3%) and uncontrolled (n = 38; 50.7%) groups based on glycemic status. TCF7L2 rs7903146 genotypes (CC, CT, TT) were identified, and anthro­pometric parameters (height, body weight, BMI, waist circumference, and muscle mass) were analyzed using chi-square or Fisher’s exact tests, with additional analyses for continuous variables. Results: The most frequent genotype was CT (69.3%), followed by TT (25.3%) and CC (5.3%). No significant differences were observed in anthropometric parameters across TCF7L2 rs7903146 genotypes in both controlled and uncontrolled groups, including BMI (p= 0.580 and p= 0.830), waist circumference (p= 1.000 and p= 0.760), and muscle mass (p= 1.000 and p= 0.420), respectively. Conclusion: The TCF7L2 rs7903146 polymorphism was not associated with anthropometric profiles among patients with T2DM, regardless of glycemic control status. This suggests that the influence of TCF7L2 is more strongly related to metabolic regulation through insulin signaling pathways rather than to determinants of body composition.

  • Open Access

    Peroxisome Proliferator-Activated Receptor Gamma (PPARG2) rs3856806 Gene Polymorphism as a Risk Factor for Type 2 Diabetes Mellitus

    by Fauzaan Azhar Rizqulloh, Donny Nauphar, Tiar Masykuroh Pratamawati

    Background: Diabetes Mellitus (DM) is a long-term metabolic illness brought on by either insufficient or inefficient insulin production by the pancreas. Worldwide, 537 million adults between the ages of 20 and 79 are thought to have DM. Genetics is one of the risk factors involved in the pathophysiology of type 2 DM. The gene encodes PPARG2 protein, a group of proteins that are part of the core receptor in carbohydrate and lipid metabolism. Among the two isoforms, PPARG2 is specific to adipose tissue and plays an important role in adipogenesis and mediating insulin sensitivity. Aims: This study aims to examine the PPARG2 rs3856806 gene polymorphism as a risk factor for the occurrence of type 2 diabetes mellitus in the Cirebon population. Methods: This case-control study involved 30 cases of type 2 DM and 30 healthy controls. Data were obtained with blood sugar level test, DNA extraction, and PCR-RFLP with Eco72I restriction enzyme, followed by visualization of results using gel electrophoresis. Results: The C Allele frequency was higher in the case group (76.6%) while the T Allele frequency was higher in the control group (56.6%). The CT heterozygote genotype frequency was more common in the control group (86.7%) and the TT homozygous mutant genotype frequency was higher in the case group (3%) compared to the control group (0%). The results of the Chi-Square Test obtained a p-value of 0.001 with an OR value of 0.118 (CI95%=0.033-0.422). Conclusion: The PPARG2 rs3856806 polymorphism was significantly associated with lower odds of type 2 diabetes mellitus in the population of Cirebon, Indonesia, when analyzed under a dominant genetic model comparing T-allele carriers (CT + TT) to non-carriers (CC).

  • Open Access

    Efektivitas Virtual Reality Upper Motoric Training Terhadap Pemulihan Fungsi Motorik Atas Pada Pasien Stroke

    by Muhammad Firyal Pradana, Hendry Gunawan, Donny Nauphar

    Latar Belakang: Stroke merupakan penyebab utama disabilitas jangka panjang dengan gangguan fungsi motorik atas yang signifikan, sehingga mengganggu aktivitas harian pasien. Rehabilitasi dengan metode konvensional memiliki keterbatasan dalam hal keterlibatan pasien dan efektivitas jangka panjang. Inovasi terapi menggunakan Virtual Reality Upper Motoric Training (VRUMT) telah berkembang sebagai pendekatan alternatif yang interaktif dan menarik dalam pemulihan motorik pasca stroke. Tujuan: Mengetahui efektivitas Virtual Reality Upper Motoric Training terhadap pemulihan fungsi motorik atas pada pasien stroke di RSU Universitas Muhammadiyah Cirebon. Metode: Penelitian ini menggunakan desain kuasi-eksperimental dengan pendekatan pre-test post-test with nonequivalent control group. Sampel sebanyak 20 pasien stroke yang dibagi menjadi kelompok intervensi (VRUMT) dan kelompok kontrol (fisioterapi konvensional). Penilaian fungsi motorik atas dilakukan menggunakan instrumen Fugl-Meyer Assessment Upper Extremity (FMA-UE) sebelum dan sesudah intervensi. Hasil: Kelompok intervensi menunjukkan peningkatan signifikan skor FMA-UE dibandingkan kelompok kontrol. Hasil uji statistik bivariat menunjukkan nilai signifikansi (p < 0,05), menandakan bahwa Virtual Reality Upper Motoric Training efektif dalam meningkatkan fungsi motorik atas pasien stroke. Simpulan: Virtual Reality Upper Motoric Training terbukti efektif dalam meningkatkan pemulihan fungsi motorik atas pada pasien stroke, dan dapat dipertimbangkan sebagai terapi alternatif yang inovatif dan menarik dalam program rehabilitasi stroke.

  • Open Access

    Angiotensin Converting Enzyme 2 (ACE2) G8790A Gene Polymorphism as a Risk Factor for Essential Hypertension

    by Nazaul Husna, Donny Nauphar, Tiar Masykuroh Pratamawati

    Background: Globally, the number of people with hypertension has doubled, from 650 million to 1.3 billion. The World Health Organization reported that hypertension is responsible for more than 10 million deaths every year. Essential hypertension is a multifactorial condition with genetics as one of the factors. Genome-Wide Association Study has identified several genes associated with hypertension, one of which is the Angiotensin Converting Enzyme 2 (ACE2) gene. Essential hypertension may be predisposed to by the G8790A polymorphism of the ACE2 gene, which is hypothesized to interfere with the normal function of the Renin Angiotensin System (RAS). Aims: The purpose of this study is to determine whether the ACE2 G8790A gene polymorphism in Cirebon, West Java, Indonesia, is associated with an increased risk of essential hypertension. Methods: This is a case-control study conducted at the Talun Health Center, Cirebon Regency, April-August 2024, involving 30 essential hypertensive patients and 30 healthy controls. The study population comprised adults aged 30 to 72 years. Data was obtained through the examination of blood pressure, DNA extraction, PCR-RFLP with ALUI restriction enzyme, and then visualization of the results with Gel Electrophoresis. The Chi-Square Test technique and the Odds Ratio (OR) computation were used to analyze the data. Results: The G allele was higher in the case group 33 (55%), while the A allele was higher in the control group 34 (56.7%). The statistical analysis showed that there was no significant link between the ACE2 G8790A gene variation and essential hypertension, with a p-value of 0.592 (p > 0.05) (OR = 0.750; CI = 0.262–2.151). Conclusion: The ACE2 gene G8790A polymorphism and the rate of hypertension in Cirebon, West Java, were not significantly correlated. Further research is required on a larger scale to investigate the effects of gene combinations or interactions with other locus genes on essential hypertension.


  • Open Access

    TNF-α -308 G/A Gene Polymorphism as a Risk Factor for Pulmonary Tuberculosis in Cirebon, Indonesia

    by Nurfithria Oktaviyati, Tiar Masykuroh Pratamawati, Donny Nauphar

    Background: Mycobacterium tuberculosis, the causative agent of pulmonary tuberculosis, spreads via droplets. The TNF-α-308 G/A gene polymorphism is one of the host genetic variables that may affect an individual's vulnerability to the disease. However, this polymorphism has not been studied in Cirebon. Aims: To analyze the TNF-α -308 G/A gene polymorphism as a risk factor for the occurrence of pulmonary tuberculosis in Cirebon. Methods: A total of 64 participants joined part in an analytical observational study using a case-control design at the Biomolecular and Genetics Laboratory, Faculty of Medicine, Universitas Swadaya Gunung Jati, Indonesia. DNA extraction from blood samples, ARMS-PCR genotyping, and 1.5% electrophoresis gel visualization were all part of the data gathering process. The chi-square test was used to analyze the data. This study including inclusion criteria, exclusion criteria, and sample control for the research. Results: According to the study, there is no link between Cirebon's risk of pulmonary tuberculosis and the polymorphism in the TNF-α-308 G/A gene (OR = 0.462; P > 0.05). However, the study shown a protective factors which means that individuals with the TNF-α -308 G/A gene polymorphism have a lower risk of developing pulmonary tuberculosis compared to those without the polymorphism. Conclusion: The TNF-α-308 G/A gene variant is not associated with an increased risk of pulmonary tuberculosis in the Cirebon community.


  • Open Access

    Potassium Inwardly Rectifying Channel Subfamily J Member 11 (KCNJ11) RS5219 Gene Polymorphism as a Risk Factor for Type 2 Diabetes Mellitus in Indonesia: A Case Control Study

    by Annisa Septiani Putri Putri, Tiar Masykuroh Pratamawati, Donny Nauphar

    Background: Diabetes Mellitus (DM) is a chronic metabolic disease caused by the failure of the pancreas to produce the hormone insulin or ineffective use of the hormone insulin. It is estimated that 537 million adults aged 20-79 years worldwide suffer from DM. Genetics is one of the risk factors involved in the pathophysiology of type 2 DM. The KCNJ11 gene encodes the Kir6.2 protein that is responsible for adenosine triphosphate-sensitive potassium ion channels (kATP) synthesis in pancreatic beta cells plasma membrane. Aims: This study aims to examine the KCNJ11 rs5219 gene polymorphism as a risk factor for type 2 diabetes mellitus in Cirebon population. Methods: This case control study involved 29 cases of type 2 diabetes mellitus and 29 healthy controls with purposive sampling technique. Sample data was obtained through the examination of blood sugar, DNA extraction, PCR-RFLP with Eco24I restriction enzyme, then visualization of the results with Gel Electrophoresis. Results: The frequency of G allele was found more in the case group (70%) while the frequency of A allele was found more in the control group (38%). The frequency of heterozygous GA genotype was found more in the control group (48.3%) and the frequency of homozygous mutant AA genotype was more in the case group (17.2%) compared to the control group (13.8%). Chi-Square Test results obtained p-value 0.115, OR value 2.318. Conclusion: This study showed no significant association between Potassium Inwardly Rectifying Channel Subfamily J Member 11 (KCNJ11) rs5219 gene polymorphism and the incidence of Type 2 Diabetes Mellitus in Cirebon population.


  • Open Access

    Angiotensin-Converting Enzyme Insertion/Deletion (ACE I/D) Gene Polymorphism as a Risk Factor for Essential Hypertension

    by Hasna Nurazizah Kuswara, Donny Nauphar, Ariestya Indah Permata Sari

    Background: Hypertension is the leading cause of death globally due to its complications, including coronary heart disease and stroke. In 2018, hypertension cases in West Java were the second highest among all populations in Indonesia. Genetics is one of the unmodifiable risk factors for hypertension. Angiotensin-converting enzyme insertion/deletion (ACE I/D) gene polymorphism could affect ACE production in the renin-angiotensin-aldosterone system (RAAS), which is linked to the regulation of blood pressure. Aims: To analyze ACE I/D gene polymorphism as a risk factor for hypertension in Cirebon. Methods: An observational analysis with a case-control design was used in this study. Blood samples were collected from 30 hypertensive patients and 30 healthy individuals at Talun Health Center. DNA extraction was performed to evaluate polymorphisms using ARMS-PCR. Statistical analyses, including the Chi-square test, Fisher’s exact test, Mann-Whitney, and Kruskal-Wallis test, were conducted to compare the case and control groups. The odds ratio was calculated to see the risk of the assessed variables, including genotype, allele frequency, and the presence of ACE I/D gene polymorphism. Results: In the case group, the frequency of the II genotype was 2 (6.7%), the ID genotype was 25 (83.3%), and the DD genotype was 3 (10.0%). In the control group, the frequency of the II genotype was 2 (6.7%), the ID genotype was 26 (86.7%), and the DD genotype was 2 (6.7%). Statistically, there was no significant association between ACE I/D gene polymorphisms in essential hypertension patients and healthy people (p=0.500; OR=1.556; 95% CI=0.241-10.049). Conclusion: ACE I/D gene polymorphism was not significantly associated with essential hypertension in Cirebon, West Java, Indonesia. Received: 25 September 2024 | Reviewed: 21 October 2024 | Revised: 23 November 2024 | Accepted: 30 November 2024.


  • Open Access

    Molecular analysis of exon 7 of the fibroblast growth factor receptor 2 (FGFR2) gene in an Indonesian patient with Apert syndrome: a case report

    by Gara Samara Brajadenta, Ariestya Indah Permata Sari, Donny Nauphar, Tiar Masykuroh Pratamawati, Vincent Thoreau

    Apert syndrome, Online Mendelian Inheritance in Man number 101200, is a rare genetic condition, with autosomal dominant inheritance, characterized by craniosynostosis, midfacial malformation, and severe symmetrical syndactyly. Apert syndrome is associated with other systemic malformations, including intellectual disability. At least seven mutations in fibroblast growth factor receptor 2 (FGFR2) gene have been found to cause Apert syndrome. Most cases of Apert syndrome are caused by one of the two most frequent mutations located in exon 7 (Ser252Trp or Pro253Arg). A 27-year-old Javanese man presented borderline intellectual functioning and striking dysmorphisms. A clinical diagnosis of Apert syndrome was previously made based on these clinical features. Furthermore, POSSUM software was used before molecular analysis and the result showed suspected Apert syndrome with a cut-off point of 14. Molecular genetic analysis of FGFR2, targeting exon 7, was performed by direct sequencing. In this patient, a missense mutation c.755C>G was detected, changing a serine into a tryptophan (p.Ser252Trp). We report the case of an Indonesian man with Apert syndrome with a c.755C>G (p.Ser252Trp) mutation in the FGFR2 gene. Our patient showed similar dysmorphism to previously reported cases, although cleft palate as a typical feature for p.Ser252Trp mutation was not present. In spite of the accessibility of molecular genetic testing in a few parts of the world, the acknowledgement of clinically well-defined syndromes will remain exceptionally imperative in developing countries with a lack of diagnostic facilities.